Paper21865415
Benign multiple sclerosis: a new definition of this entity is needed.
Correale J and 2 others. Mult Scler, 2012. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. Benign multiple sclerosis: a new definition of this entity is needed. Papers, record 21865415. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21865415
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Disability Evaluation | Major topic |
| Multiple Sclerosis | Major topic |
| Severity of Illness Index | Major topic |
| Adult | |
| Cognition Disorders | |
| Depression | |
| Fatigue | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Incidence | |
| Magnetic Resonance Imaging | |
| Male | |
| Neuropsychological Tests | |
| Pain | |
| Prognosis | |
| Prospective Studies | |
| Quality of Life |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41191123 | Benign multiple sclerosis and long-term outcomes after 30 years. | J Neurol | 2025 | https://conductscience.org/library/papers/41191123 | PubMed |
| 39494361 | Early regional cerebral grey matter damage predicts long-term cognitive impairment phenotypes in multiple sclerosis: a 20-year study. | Brain Commun | 2024 | https://conductscience.org/library/papers/39494361 | PubMed |
| 38488979 | Holistic, Long-Term Management of People with Relapsing Multiple Sclerosis with Cladribine Tablets: Expert Opinion from France. | Neurol Ther | 2024 | https://conductscience.org/library/papers/38488979 | PubMed |
| 38420491 | Predictive factors and treatment challenges in malignant progression of relapsing-remitting multiple sclerosis. | Heliyon | 2024 | https://conductscience.org/library/papers/38420491 | PubMed |
| 35680693 | Symptom Interconnectivity in Multiple Sclerosis: A Narrative Review of Potential Underlying Biological Disease Processes. | Neurol Ther | 2022 | https://conductscience.org/library/papers/35680693 | PubMed |
| 35598225 | Patterns of Utilization and Expenditure Across Multiple Sclerosis Disease-Modifying Therapies: A Retrospective Cohort Study Using Claims Data from a Commercially Insured Population in the United States, 2010-2019. | Neurol Ther | 2022 | https://conductscience.org/library/papers/35598225 | PubMed |
| 33791847 | Long-term analysis of patients with benign multiple sclerosis: new insights about the disability course. | J Neurol | 2021 | https://conductscience.org/library/papers/33791847 | PubMed |
| 32763899 | Disability Improvement Is Associated with Less Brain Atrophy Development in Multiple Sclerosis. | AJNR Am J Neuroradiol | 2020 | https://conductscience.org/library/papers/32763899 | PubMed |
| 31556809 | Cytokine-chemokine and cognitive profile of multiple sclerosis patients with predominant optic nerve and spinal cord involvement. | J Spinal Cord Med | 2021 | https://conductscience.org/library/papers/31556809 | PubMed |
| 30884218 | Impairment and restrictions in possibly benign multiple sclerosis. | Brain Behav | 2019 | https://conductscience.org/library/papers/30884218 | PubMed |
| 30742302 | Spatial distribution of white matter degenerative lesions and cognitive dysfunction in relapsing-remitting multiple sclerosis patients. | Neurol Neurochir Pol | 2019 | https://conductscience.org/library/papers/30742302 | PubMed |
| 30303036 | Recommendations for cognitive screening and management in multiple sclerosis care. | Mult Scler | 2018 | https://conductscience.org/library/papers/30303036 | PubMed |
| 28966652 | Optical coherence tomography and T cell gene expression analysis in patients with benign multiple sclerosis. | Neural Regen Res | 2017 | https://conductscience.org/library/papers/28966652 | PubMed |
| 27416843 | Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC). | BMC Neurol | 2016 | https://conductscience.org/library/papers/27416843 | PubMed |
| 25899600 | Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disability. | BMC Neurol | 2015 | https://conductscience.org/library/papers/25899600 | PubMed |
| 24041438 | Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration. | Eur J Radiol | 2013 | https://conductscience.org/library/papers/24041438 | PubMed |
| 23643443 | Tract-specific white matter correlates of fatigue and cognitive impairment in benign multiple sclerosis. | J Neurol Sci | 2013 | https://conductscience.org/library/papers/23643443 | PubMed |
| 23473637 | Multiple sclerosis: molecular mechanisms and therapeutic opportunities. | Antioxid Redox Signal | 2013 | https://conductscience.org/library/papers/23473637 | PubMed |
| 22777531 | Benign multiple sclerosis: does it exist? | Curr Neurol Neurosci Rep | 2012 | https://conductscience.org/library/papers/22777531 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21865415
GET https://conductscience.org/api/papers/v1/21865415/authors